Background {#Sec1}
==========

An early and precise pregnancy diagnosis is an important criterion for better reproductive management in livestock like cows and buffaloes. Currently different methods (direct and indirect) are in use for diagnosis of pregnancy. The direct methods include per rectal palpation and ultrasonography. However, their application is limited in terms of accurate detection by day 45th and 30th day using per rectal palpation and ultrasonography respectively \[[@CR1], [@CR2]\]. Additionally, the expertise of experienced veterinarian is required for confirmed pregnancy diagnosis. The indirect methods include immunological based assay for detection and quantitation of target proteins (Pregnancy Associated Glycoprotein: PAG) and hormones such as progesterone (P~4~), pregnadiol, interferon tau related to pregnancy \[[@CR3], [@CR4]\]. However, these methods have inherent limitations of specificity and false positive results in ELISA. Worldwide, different research groups have used urine as a non-invasive source for detection of pregnancy and various other diseases in human being. Pregnancy diagnosis (PD) in dairy animals has remained elusive till date. In fact, dairy animals (cow, buffalo, sheep and goat) although domesticated since time immemorial offer inherent challenges in the understanding of their anatomy, physiology and behavior. Pregnancy in human being is currently detected by presence of human chorionic gonadotropin (HCG) in urine. However, this hormone is absent in bovine urine. Therefore, till date early pregnancy detection in bovine has not been possible \[[@CR5]--[@CR7]\]. After conception, numerous biomolecules such as steroids, prostaglandins and proteins are expressed during early pregnancy \[[@CR8]\]. Many of these hormones and proteins are of fetal-placental origin rather than of maternal origin \[[@CR9]\]. They are required for the successful establishment of pregnancy and the proliferation of normal and neoplastic cells. Early pregnancy factor (EPF) is one protein which has been observed in the serum of cows during early pregnancy. However, EPF is not confined to pregnancy specifically but also detected in the serum of patients and different animals bearing a variety of tumors \[[@CR10]\].

The increased expression of PAG has also been reported in serum and milk during pregnancy in bovine. PAGs are expressed specifically in the maternal and embryonic regions of placenta and belong to aspartic protease family. Different isoforms of PAGs have been reported in bovine during various stages of gestation. The presence of this protein after 28th day post AI serves as an indicator of pregnancy \[[@CR11]\]. However, this protein has inherent limitation because its maintenance of basal level of expression till 3 months after parturition. No other proteins till now have been suggested as suitable biomarker for early detection of pregnancy. Thus, although there have been many attempts to develop diagnostics for the detection of early pregnancy in cattle, no success has been achieved till date.

Progress in the field of protein separation and identification technologies has accelerated research into biofluids proteomics for protein biomarker discovery. Urine is considered as an ideal source of biological material for biomarker discovery as it is non-invasive in comparison to other body fluids \[[@CR12]\]. Lack of reliable cow-side early pregnancy diagnosis method further aggravates the situation. Urine is an ideal and a rich source of biomarkers in proteomics to analyze the differential expression of urinary proteins in various altered physiological conditions such as pregnancy and different diseases \[[@CR13]\] in livestock. The advancement of molecular techniques such as proteomics and their applications in animal research has given a new hope to look for pregnancy biomarkers. In the present investigation, we have identified and analyzed differentially expressed proteins urine of pregnant and non-pregnant cattle on different days of pregnancy using DIGE and Label Free Quantitation (LFQ).

Methods {#Sec2}
=======

Animal selection and sampling {#Sec3}
-----------------------------

Karan Fries (KF) heifers from the dairy herd of National Dairy Research Institute, Karnal, India were maintained under expert veterinary supervision. For the present investigation, one litre urine was collected from individual animal (n = 6) in urine bags on different days of pregnancy (0, 16, 22 and 35 days). Day 0 represents the control (collection of urine before artificial insemination: AI). Following AI, urine was collected the cows till the 60th day of pregnancy. Immediately after urine collection, phenylmethylsulfonyl fluoride (PMSF, 0.01 %) was added to prevent proteolytic degradation.

Confirmation of pregnancy using transrectal-ultrasonography {#Sec4}
-----------------------------------------------------------

The transrectal-ultrasonography (Aloka Prosound, Switzerland) was done on the 30th day after breeding and repeated after 45 days post breeding for confirmation. The scanning of the uterus and ovaries was done using a 6.5 MHz rectal linear probe (Aloka UST-5820-5, Switzerland). Pregnancy diagnosis was confirmed by observation of embryocoele and allantoic fluid \[[@CR14]\]. The ovaries were scanned for the presence of corpus luteum also.

Sample preparation {#Sec5}
------------------

Insoluble material in urine was removed by centrifugation at 6000 rpm for 30 min, followed by diafiltration with phosphate buffer saline (PBS, pH 7.5) (133 mM NaCl, 2.7 mM KCl, 10 mM Na~2~HPO~4~ and 2 mM KH~2~PO~4~) \[[@CR12], [@CR15]\]. The diafiltered urine was concentrated up to 100 ml by using 3 kDa hollow fibre cartridge in Marlow Benchtop System (GE healthcare, USA). Protease inhibitor cocktail (Sigma, USA) was added to the concentrated urine to prevent proteolysis and stored at −80 °C till further use.

Protein precipitation {#Sec6}
---------------------

Protein precipitation from the concentrated urine was performed by Proteo Spin Maxi Kit (Norgen Biotek, USA) following manufacturer's instructions. Briefly, the pH of the urine sample was adjusted to 3.5 by adding a binding buffer. The Proteo Spin column was activated by adding 5 ml of the column activation and wash buffer and centrifuged for 3 min at 1000×*g*. The flow through was discarded and same step was repeated twice and 20 ml of the pH adjusted urine was loaded onto the column and centrifuged for 5 min at 1000×*g*. The column was again washed by applying column activation and wash buffer and centrifuged for 3 min at 1000×*g*. Protein was eluted with elution buffer (10 mM Na~2~HPO~4~, pH 12.5) in a fresh collection tube containing the neutralizer. The eluted proteins were concentrated and preserved at −80 °C until further analysis \[[@CR16]\].

Clean up {#Sec7}
--------

Interfering substances such as salts, detergents, nucleic acid, etc. were removed from the precipitated urinary proteins using 2-D clean-Up kit (GE healthcare, USA) and the resulting pellet were rehydrated in lysis buffer (7 M Urea, 2 M Thiourea, 4 % CHAPS, 30 mM Tris). Protein concentration was estimated using 2-D Quant kit (GE Healthcare, USA) as per manufacturer's instructions with bovine serum albumin as a standard.

1D SDS-PAGE {#Sec8}
===========

The individual proteins were precipitated and analysed by (10 × 10.5 cm) SDS-PAGE with 4 % stacking and 12 % resolving gel using MiniVE gel electrophoresis apparatus (GE healthcare, USA). The gels were stained with Coomassie Brilliant Blue G 250 (Bio-Rad Laboratories, USA) for 1 h and destained.

Sample labelling with fluorescent dyes {#Sec9}
--------------------------------------

The sample pH was adjusted to 8.5 by 100 mM NaOH. An equal amount of proteins was pooled (n = 6) separately to make a final amount of 15 µg for each day of sample i.e. 0, 16, 22 and 35 days, the protein samples were labelled with 200 pmol Cy3 (non-pregnant) and Cy5 (pregnant) respectively. Internal standard (pooled sample, 7.5 µg each) was labelled with 200 pmol Cy2 dye. Dye swapping was done to avoid dye biasness by labelling with 200 pmol Cy5 (non-pregnant) and Cy3 (pregnant) respectively. The whole labelling procedure was performed on ice, after labelling samples are incubated in dark for 30 min. Subsequently, 1 µl of 10 mM lysine was added to quench the reaction. The samples were incubated for 10 min on ice in dark and mixed as per the experimental design (Table [1](#Tab1){ref-type="table"}). The final sample volume was made 125 µl for each strip, by adding De Streak rehydration buffer (GE Healthcare). Six IPG (7 cm, pH 4--7, GE Healthcare) were rehydrated by passive rehydration with labelled sample for 16 h at room temperature following the protocol described by Jena et al \[[@CR17]\].Table 1Experimental design for DIGE experiment (0, 16, 22 and 35 day of pregnancy)GelsCy2Cy3Cy5Gel 115 μg (3.75 μg each of samples 0,16, 22 and 35 days)15 μg sample 0 day15 μg sample 16 dayGel 215 μg (3.75 μg each of samples 0,16, 22 and 35 days)15 μg sample 0 day15 μg sample 22 dayGel 315 μg (3.75 μg each of samples 0,16, 22 and 35 days)15 μg sample 0 day15 μg sample 35 dayGel 415 μg (3.75 μg each of samples 0,16, 22 and 35 days)15 μg sample 16 day15 μg sample\
0 dayGel 515 μg (3.75 μg each of samples 0,16, 22 and 35 days)15 μg sample 22 day15 μg sample\
0 dayGel 615 μg (3.75 μg each of samples 0,16, 22 and 35 days)15 μg sample 35 day15 μg sample\
0 day

2D GE and image scanning {#Sec10}
========================

Isoelectric focusing (IEF) was performed with the parameters 150 V for 1 h 20 min (step), 300 V for 20 min (grad), 5000 V for 1 h 40 min (grad), 5000 V for 25 min (step) with a total of 7000 Vh. Thereafter, strips were equilibrated with an equilibration buffer (6 M Urea, 50 mM Tris pH 8.8, 2 % SDS, 30 % Glycerol and 0.02 % Bromophenol Blue) containing 1 % DTT for 15 min (reduction) and followed by an equilibration buffer containing 2.5 % iodoacetamide for another 15 min (alkylation). SDS-PAGE of 6 gels was performed in MiniVE (GE healthcare, USA) electrophoresis system (10 × 10.5 cm) with 12 % resolving gel. After electrophoresis, gels were scanned with typhoon Trio+ variable mode imager (GE Healthcare) by using the parameters followed earlier with minor modifications \[[@CR17], [@CR18]\]. Briefly, the gels were scanned with 100 µm resolution and normal sensitivity. Cy2 images were scanned with 575 nm (blue) laser and 520 BP40 emission filter, Cy3 images were scanned with 515 nm (green) laser and 580 BP30 emission filter and Cy5 images were scanned with 490 nm (red) laser and 670 BP30 emission filter.

Image analysis and spot picking {#Sec11}
-------------------------------

Scanned images were analyzed in the Decyder 2-D software (version 7.0, GE Healthcare) to identify expression of proteins. Estimated number of spots was set to 2000 and in individual gel spots were detected by Differential In-Gel analysis (DIA). All images from 6 different gels were matched through Biological Variation Analysis (BVA) which provides statistical data for differentially expressed proteins (above 1.5 fold, p ≤ 0.05) between three experimental groups. A total of 11 differentially expressed protein spots were identified.

Preparative gel and spot digestion {#Sec12}
----------------------------------

A preparative gel having 320 µg pooled (n = 6) proteins from various days of pregnant animals (0, 16, 22 and 35 days) was carried out using the same parameters used for DIGE as mentioned above and stained with Coomassie Brilliant Blue (R-350) followed by destaining. Selected spots were picked from preparative gel and transferred into 1.5 ml Eppendorf tubes, spots were washed with Milli-Q water and 40 mM NH~4~HCO~3~ in 50 % ACN (1:1) and for rehydration 100 µl of 100 % ACN were added to each tube and incubated for 10 min, ACN was carefully discarded and for reduction 10 mM DTT in 40 mM NH~4~HCO~3~ buffer was added and incubated for 15 min, then alkylation was done in 55 mM iodoacetamide in 40 mM NH~4~HCO~3~ buffer. Spots were washed and rehydrated. For tryptic digestion spots were covered with trypsin solution (12.5 ng/µl in 50 mM NH~4~HCO~3~) for 45 min in ice. Trypsin digestion was performed overnight at 37 °C and stopped by adding 5 % formic acid. The extracted peptides were dried in a Speed-Vac and desalted by using Ziptip (Millipore, USA) and identified by Nano-LC-MS/MS.

In- solution digestion {#Sec13}
----------------------

For in-solution digestion, 20 μg of pooled samples (n = 6) from non-pregnant and pregnant cows (0, 16, 22 and 35 days) were collected on different days of pregnancy was processed. In solution digestion method was performed as reported earlier with slight modification \[[@CR16]\]. In brief, 45 mM DTT in 50 mM NH~4~HCO~3~ was used to reduce disulfide bonds followed by alkylation of cysteine residues using 10 mM IAA in 50 mM NH~4~HCO~3~. Digestion was carried out overnight using trypsin (1:20) (modified sequencing grade; Promega, USA) at 37 °C. The reaction was subsequently stopped with 10 % TFA, peptides were vacuum dried, desalted by zip tip and stored at −80 °C.

LC-MS/MS and data analysis for label free quantitation (LFQ) {#Sec14}
------------------------------------------------------------

The digested peptides were reconstituted in 0.1 % formic acid in LC/MS grade water and subjected to nano-LC (Nano-Advance, Bruker, Germany) followed by identification in captive spray-Maxis-HD qTOF (Bruker, Germany) mass spectrometer (MS) with high mass accuracy and sensitivity. The peptides were enriched by nano trap column (Bruker Magic C~18~AQ, particle size-5 μm, pore size-200 Å) and separated on an analytical column (Bruker Magic C~18~AQ, 0.1 × 150 mm, 3 μm particle size, and 200 Å pore size) at flow rate 800 nl/min and eluted using a linear gradient of 5−45 % acetonitrile over 135 min. The MS/MS scan was carried out at m/z range of 400--1400 followed in data dependant mode. For each cycle, the six most intense precursor ions from survey scan were selected for MS/MS \[[@CR16]\]. The identification and quantitation was done using MS/MS spectra.

Data processing and bioinformatics analysis {#Sec15}
-------------------------------------------

MS data were analyzed using MaxQuant \[[@CR19]\] software version 1.5.0.8 and searched with UniProt *Bos taurus* and *Bubalus bubalis* database along with common contamination sequences. Database search was performed in MaxQuant environment integrated with Andromeda. For searching, the enzyme specificity was set to trypsin with the maximum number of two missed cleavages. The precursor mass tolerance was assigned to 0.07 Da for the first search and 0.006 Da for the main search. Mass tolerance for matching peaks to theoretical ion series was set to 40 ppm. The false discovery rate (FDR) for PSM, protein, and site decoy fraction was set to 1 %. The search included variable modifications of protein N-terminal acetylation, methionine oxidation, and carbamidomethylation of cysteines was searched as a fixed modification. The maximal number of modifications per peptide was set to be 6. The minimum peptide length of 6 was set, and the 'peptide re-quantification' function was enabled. To validate and transfer identifications across different runs, the 'match between runs' option in MaxQuant was enabled with a retention time window of 0.7 min and an alignment time window of 20 min. Subsequent bioinformatics analysis were performed using Protein Analysis Through Evolutionary Relationships (PANTHER) to compare the GOBP, GOCC, GOMF and GOPC. The obtained PANTHER \[[@CR20]\] data was further analyzed and graphs were prepared using MS Excel 2007. The mass spectrometry proteomics data have been deposited to the ProteomeXchange consortium with the PRIDE partner repository with the database identifier PXD004122.

Result and discussion {#Sec16}
=====================

Urine is considered to be the best source of biological material for diagnosis of altered physiological and various patho-physiological conditions due to its non-invasive nature and collection in large volume \[[@CR12]\]. It is a well known fact that pregnancy affects the protein expression in maternal serum and urine. Furthermore, the quantitative difference in protein expression during pregnancy is useful for the detection of biomarkers related to pregnancy. In the present investigation, we have used gel based (DIGE) and non-gel based approaches (LFQ) to identify differentially expressed proteins during early pregnancy in cattle (Fig. [1](#Fig1){ref-type="fig"}). The present study aimed to identify protein biomarkers which can possibly be used for detection of pregnancy at an earlier stage (16--25 days) in cow urine samples which will be beneficial for dairy farmers.Fig. 1Workflow of the DIGE and LFQ for identification of differential expressed proteins during various time points of pregnancy

Identification of differentially expressed proteins (DEP) using DIGE {#Sec17}
--------------------------------------------------------------------

We used DIGE approach to identify the differentially expressed proteins during different days of pregnancy, such as days 0 (non-pregnant control), 16, 22 and 35 post breeding. A representative image of the DIGE gel in the present investigation is shown in Fig. [2](#Fig2){ref-type="fig"}a, b. Additional figures of all DIGE gels are shown in Additional file [1](#MOESM1){ref-type="media"}: Figure S1. After analysis of the DIGE gel in Decyder software, we observed a total of 11 differentially expressed proteins (DEPs) having fold change of ±1.5 (*p* ≤ 0.05). Out of 11 DEPs, 9 proteins were up-regulated (Table [2](#Tab2){ref-type="table"}). We have discussed functional relevance of few selected proteins namely Alpha 2HS Glycoprotein (A2HS), AMBP, Renin, Mannan-binding protein which may have role in pregnancy associated events. Alpha-2-HS (Heremans-Schmid) glycoprotein also known as Fetuin-A is a phosphoprotein which is mainly expressed in the liver, the tongue, and placenta in humans \[[@CR21]\]. It is expressed in higher concentrations in serum and amniotic fluid during fetal life and is also involved in development-associated regulation of calcium metabolism and osteogenesis. The increased expression of this protein has been reported during pregnancy in women \[[@CR13]\]. Interestingly, we observed secretion of this protein in the urine of pregnant cows during early pregnancy. The renin--angiotensin system (RAS) is mainly associated with the regulation of blood pressure and ion homeostasis. Angiotensin II (Ang II) which is generated due to the proteolytic action of rennin has been reported to influence oviductal gamete movements and foetal development. The pre-implanted embryo responds to Ang II from mothers rather than from embryos. It has been suggested that maternal RAS influences blastocyst hatching and early embryonic development \[[@CR22]\]. Alpha-2 Macroglobulin (AMBP) is a protease inhibitor and has been reported to prevent excessive trophoblastic invasion. AMBP reportedly influences trophoblast invasion in human pregnancy, which would be reflected in its increased production in the decidua basalis \[[@CR23]\]. We also observed up-regulation of Mannan-binding protein (MBP) in our experiment. MBP is a mannan-binding lectin which is secreted into the amniotic fluid and its functional activity is mediated through the formation of mannose-binding lectin and mannose-binding lectin-associated serine protease 2 complexes (MBL-MASP2 complex). This complex is actively involved in mannose-binding lectin complement pathway resulting in antibody-independent recognition and clearance of pathogen in the amniotic cavity during pregnancy \[[@CR24], [@CR25]\]. Increased secretion of MBP in urine during early pregnancy suggests its possible application as a potential biomarker.Fig. 2**a** Images of DIGE gels scanned using Typhoon Scanner. **b** Image of preparative gel (320 µg protein on 7 cm IPG strip having pI-4-7 and 12 % separating gel) used for picking differential expressed proteinsTable 2List of differentially expressed proteinsSpot IDProteinGene symbol16 vs 022 vs 035 vs 0ScoreSeq. coverage (%)MW (kDa)pINo. of peptides311Alpha-1B-glycoproteinAIBG−1.0−1.21.5112.755.0053.505.302318Protein AMBPAMBP1.82.01.2425.6122.7039.207.818376Allergen Bos d 2ALL22.3−1.01.1654.3140.7019.504.6610399TransthyretinTTHY1.31.5−1.1227.6130.6015.705.904402Carbonic anhydrase 2CAH21.31.7−1.1297.0828.5029.106.415410Chain L, crystal structure of bovine antibody)3.2−1.0−1.059.907.9022.505.871418Cathelicidin-4 precursor2.0−1.0−1.2458.2738.2016.506.296314Renin receptorRENR−1.4−1.41.6268.8010.8039.505.355400Mannan-binding lectin serine peptidase 21.72.12.61038.3150.4445.372

Identification of differentially expressed proteins by LFQ {#Sec18}
----------------------------------------------------------

Analysis of the LFQ results using Maxquant software revealed 195 (Additional file [2](#MOESM2){ref-type="media"}: Table S1) differentially expressed proteins, out of which 28 proteins were up-regulated and 40 proteins were down-regulated having fold change ≥1.5 and ≤0.6 respectively which were considered for further analysis (Tables [3](#Tab3){ref-type="table"}, [4](#Tab4){ref-type="table"}; Fig. [3](#Fig3){ref-type="fig"}). The analysis revealed some important proteins which play a role in pregnancy-associated events such as embryo implantation, establishment, and maintenance of pregnancy. Expression of important proteins such as Hormone-binding globulin, Haptoglobin, SerpinB~3~ like, Uromodulin, Cathelicidin, Mannan-binding protein, uteroglobin, Vitamin-binding protein and Insulin-like growth factor-binding protein II (IGFBP-II) increased significantly during the early days of pregnancy (16--22 days). Uterine serpins are produced by uterine endometrium and regulate the immune function or participate in the trans-placental transport. Expression of Serpin was decreased on day 10 but subsequently increased on day 16 \[[@CR26]\]. Another study revealed that there is increased expression of serpin in the endometrium of pregnant cows compared to cyclic heifers during pregnancy recognition period (16--18 days) \[[@CR27]\].Table 3LFQ (max quant) list of up regulated proteinsS. no.Protein IDProtein namePeptidesSequence coverage (%)Mol. weight (kDa)Fold change16 vs 0 days22 vs 0 days35 vs 0 days1gi\|528953246Alpha-S1-casein isoform X2212.420.11.51.91.62gi\|741932316Complement C3 isoform X11411.1187.21.65.97.03gi\|440895896Vitronectin815.553.61.71.92.84gi\|741962549Pigment epithelium-derived factor21424.21.64.65.05gi\|28603766Plasma serine protease inhibitor precursor1031.745.21.64.718.16gi\|667665642Cathelicidin, partial957.417.61.77.15.17gi\|68165959Insulin-like growth factor II, partial417.65.71.61.711.78gi\|664764564Polymeric immunoglobulin receptor21.382.92.14.27.19gi\|803268763Calbindin29.229.91.53.814.510gi\|741969869Fibulin-2 isoform X133.9124.01.812.716.811gi\|741905201Endosialin isoform X1, partial814.970.84.74.95.512gi\|803331888Plasma serine protease inhibitor619.345.41.68.912.613gi\|426254387Uromodulin1319.869.81.92.52.514gi\|440891627Cathelicidin-3, partial216.315.24.73.95.815gi\|440893899Hypothetical protein M91_15215, partial23.169.02.24.78.316gi\|440901185Ig lambda-1 chain C regions, partial568.611.11.71.66.117gi\|741954224Mannan-binding lectin serine protease 2 isoform X2634.120.33.24.711.818gi\|803247194Nectin-2 isoform X438.851.32.43.49.919gi\|528952645Extracellular superoxide dismutase \[Cu-Zn\] isoform X142226.12.14.910.620gi\|528953415Vitamin D-binding protein isoform X1618.153.32.85.94.121gi\|440906200Hypothetical protein M91_02830, partial29.419.44.31.91.822gi\|594059057Zinc-alpha-2-glycoprotein-like25.434.03.03.32.123gi\|594116459Retinol-binding protein 4-like, partial21318.51.52.79.524gi\|741973898Zymogen granule protein 16 homolog B-like318.116.96.24.81.625gi\|741976749Deleted in malignant brain tumors 1 protein isoform X49613166.57.44.34.926gi\|6137530B chain B, The crystal structure of calcium-free equine plasma gelsolin23.880.51.66.315.827P02672Fibrinogen alpha chain precursor36.267.02.13.23.328gi\|741959425Major allergen I polypeptide chain 2-like221.412.61.43.04.3Table 4List of down regulated proteinsS. no.Protein IDProtein namePeptidesSequence coverage (%)Mol. weight (kDa)Fold change16 vs 0 days22 vs 0 days35 vs 0 days1gi\|594080166Antithrombin-III31.952.40.30.40.52gi\|741962906Sex hormone-binding globulin isoform X21144.837.30.20.60.53gi\|358420932Serpin B4-like821.744.30.10.00.04gi\|57619329Actin, cytoplasmic 1933.941.70.10.40.25gi\|803211084Nuclear transport factor 2345.714.40.070.070.76gi\|371491843Peptidoglycal recognition protein 1640210.030.00.07gi\|239919016Immunoglobulin G3 heavy chain constant region, partial27.3250.340.14.38gi\|109030Ig lambda chain C region - (fragment)218.111.3110.036950.293320.041309gi\|927774498A Chain A, Bovine Allergen Bos D 2 In The Monoclinic Space Group C2744.217.80.50.090.010gi\|194206368OTU domain-containing protein 7A2179.6060.560120.633010.6026711gi\|664707994EGF-containing fibulin-like extracellular matrix protein 1 isoform X11130.154.80.20.60.412gi\|803030626Glutaminyl-peptide cyclotransferase isoform X1837.7410.30.50.513gi\|594074072Ligand isoform X323.60.40.60.40.414gi\|803074446Myeloblastin24.524.2580.106200.306180.1873315gi\|803156785Signal peptide, CUB and EGF-like domain-containing protein 2 isoform X42284.10.60.50.216gi\|741886482Neutrophil gelatinase-associated lipocalin742.722.80.10.010.0217gi\|803333753Annexin A11239.938.80.20.30.218gi\|803284484Transmembrane glycoprotein NMB46.561.60.10.60.519gi\|594070987Pantetheinase isoform X651749.90.080.10.320gi\|803234439Alpha/beta hydrolase domain-containing protein 14B317.122.40.090.50.321gi\|803299355Cadherin-19 isoform X122.686.80.50.60.322gi\|440901131Protein AMBP, partial613.537.20.40.50.523gi\|803219892Endothelial protein C receptor isoform X4528.624.70.30.60.524gi\|594051858Cartilage intermediate layer protein 1 isoform X866.2123.90.00.30.125gi\|594114749Kallikrein-1542.928.70.10.30.426gi\|440904881Dermatopontin851.323.70.10.40.327gi\|440905390Haptoglobin, partial618.544.70.020.050.0228gi\|440909177Cubilin, partial124.2396.70.010.10.0129gi\|594044657Resistin212.811.40.10.090.230gi\|440913634Leukocyte elastase inhibitor411.645.10.050.080.0331gi\|594086536Collagen alpha-3(VI) chain isoform X462.8325.10.10.40.532gi\|741942660EGF-containing fibulin-like extracellular matrix protein 1 isoform X11435.954.80.20.40.533gi\|528978722Factor XIIa inhibitor isoform X1720.551.70.020.30.234gi\|529002050Lactotransferrin isoform X12537.978.00.10.40.0535gi\|664770863Dipeptidyl peptidase 224.954.50.20.60.236Q3SZV7Q3SZV7 Similar to hemopexin414.852.20.060.40.137gi\|594103691Allergen Bos d 2-like211.118.90.10.10.138gi\|741973323Serpin B3-like isoform X2511.548.10.080.10.239gi\|440895590Growth arrest-specific protein 7, partial2035.40.030.150.140gi\|545223253Teneurin-420277.60.20.30.3Fig. 3Bar graph of differentially expressed proteins having fold change ≥1.5 and ≤0.6 revealed by Max quant Software for LFQ data

The success of pregnancy is dependent on the uterine environment which is mediated by different hormones and growth regulators. Insulin-like growth factors are expressed in embryo and reproductive tract of cow and sheep. They are reportedly involved in blastocyst formation, implantation and embryo growth \[[@CR28], [@CR29]\]. We observed up-regulation of IGFBP-II during early pregnancy. IGFBPs bind IGFs with high affinity, regulating the availability of free IGFs. Higher expression of IGFBP-II during early pregnancy suggests that it binds to IGF-II for its optimal bioavailability to embryos during implantation and embryo growth. Haptoglobin is a glycoprotein expressed in uterine epithelium during implantation period \[[@CR30]\]. We observed increased expression of this protein during early pregnancy the present study. We also observed increased expression of the vitamin D-binding protein in the urine during early pregnancy. Vitamin D-binding protein belongs to albumin family of proteins and is present in plasma, cerebrospinal and ascitic fluids and on cell surface of many cell types. This protein binds to various plasma metabolites and transport to their targeted sites. Higher expression of Vitamin D-binding protein has been reported in uterus and placenta of bovine during pregnancy \[[@CR31]\]. It has been reported that vitamin D-binding protein is also involved in active transport of Ca^+^ which is crucial for the fetal developmental events such as bone mineralization, neuro muscular activities and blood coagulation. The up-regulation of Vitamin D-binding protein in urine during early pregnancy suggests its potential as a biomarker for early detection of pregnancy in cattle. We also observed up regulation of MBP which correlates well with our DIGE data. Expression of uromodulin was also upregulated during early pregnancy in urine which is in agreement with the observation reported earlier \[[@CR32]\]. We also identified many proteins during early pregnancy (Table [3](#Tab3){ref-type="table"}) which may be playing important role in pregnancy associated events such as transfer of embryo from fallopian tube, hatching of blastocyst, maintenance and implantation of embryo and fetal development.

Functional classification of protein {#Sec19}
------------------------------------

The functional characterization of identified proteins (195 proteins) was based on Gene Ontology (GO) using PANTHER 8.0 bioinformatics software platform, which generated information regarding cellular localization, metabolic and biological process. The classification based on cellular component (Fig. [4](#Fig4){ref-type="fig"}a) revealed that the majority of proteins are present at extracellular region (54 %), followed by extracellular complex (17 %), cytoplasmic (13 %), organellar fraction (8 %), membrane and macromolecular complex (4 %). Classification based on molecular function (Fig. [4](#Fig4){ref-type="fig"}b) showed that a large majority of the proteins are involved in binding (32 %), catalytic activity (28 %), enzyme regulator activity (15 %), transporter activity (5 %), structural molecule activity (4 %) and translation regulator activity (1 %). On the basis of biological processes (Fig. [4](#Fig4){ref-type="fig"}c), the proteins were classified into those involved in metabolism and cellular processes (18 %), biological regulation (12 %), response to stimulus (11 %), immune system processes (10 %), biological adhesion, localization and developmental process (8 %), multicellular organismal process biogenesis, reproduction and apoptotic process (1 %).Fig. 4Gene Ontology classification of proteins on the basis of their involvement in **a** cellular component, **b** molecular function, **c** biological process using PANTHER 7.0 software

Network generation and visualization {#Sec20}
------------------------------------

To create protein--protein interaction network for identified urinary proteins, offline software tool Cytoscape was used along with plug-in ClueGO. The annotations network of ClueGO provides the biological significance of identified differentially expressed 195 bovine urinary proteins. ClueGO initially generates a binary gene-term matrix with the particular terms and their associated partner genes. The generated network shows the proteins as nodes that are linked through edges. During the search, the majority of the proteins were clustered into pathways (Fig. [5](#Fig5){ref-type="fig"}). From these results, four discrete pathways were recognized comprising regulation often do peptidase inhibitor activity, complement coagulation cascades, polysaccharide-binding positive regulation of peptidyl-tyrosine phosphorylation and protein kinase B signalling cascade. Regulation of these events is associated with various immunological functions. This protects the system from systemic infection and employs a number of strategies for the recognition and clearance by the host immune system \[[@CR33]\]. Pregnancy is an event when a foreign body starts growing in the womb of pregnant mother and the system reacts to the foreign body by activation of complement C pathway and induction of endopeptidases. Concomitantly, a set of endogenous protease inhibitors are also expressed in the system which may possibly protect the embryo and young foetus from the proteolytic assault and immune rejection. A large number of peptidase inhibitors e.g. AGT, AHSG, AMBP, C3, COL6A3, GAS6, KNG1, LOC784932, PAPLN, SERPINA1, SERPINF2 were identified which are involved in controlling the activity of various serine and cysteine-type endopeptidase. These protease inhibitors possibly maintains the immune system from proteolytic insult.Fig. 5Network construction for protein--protein interaction study was done using Cytoscape software with ClueGO plug-in

Conclusion {#Sec21}
==========

Although we have identified a good number of differentially expressed proteins, further validation is required to authenticate their suitability as potential biomarkers for early detection of pregnancy. The validation with advancement in high throughput mass spectrometry targeted proteomics approach is an ideal method to validate these potential biomarkers which will be part of another study. To the best of our knowledge, the present investigation reports gel based (DIGE) and non-gel based (LFQ) differential proteome profiling in pregnant *vis*-*a*-*vis* non-pregnant Karan Fries cows for the first time. It provides us important information on differentially expressed urinary proteins during early pregnancy which possibly encourages the research community and dairy industry for development of urine based pregnancy diagnostic assay for early detection of pregnancy in cattle.

Additional files {#Sec22}
================

10.1186/s12014-016-9116-y Supplimentary Table: Total identified proteins revelaed by Max quant Software.10.1186/s12014-016-9116-y List of identified proteins revealed by Max Quant Softawre.

DIGE

:   difference gel electrophoresis

MS

:   mass Spectrometry

LFQ

:   label free quantitation

DEP

:   differentially expressed proteins

MBP

:   mannan binding protein

IGF

:   insulin like growth factor

PAG

:   pregnancy associated glycoprotein

HCG

:   human chorionic gonadotropin

PD

:   pregnancy diagnosis

EPF

:   early pregnancy factor

AI

:   artificial insemination

DIA

:   differential In-Gel analysis

BVA

:   biological Variation Analysis

GO

:   gene Ontology
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